E. A. van der Veen

1.8k total citations
41 papers, 1.4k citations indexed

About

E. A. van der Veen is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Reproductive Medicine. According to data from OpenAlex, E. A. van der Veen has authored 41 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Physiology and 8 papers in Reproductive Medicine. Recurrent topics in E. A. van der Veen's work include Growth Hormone and Insulin-like Growth Factors (9 papers), Hormonal and reproductive studies (7 papers) and Ovarian function and disorders (6 papers). E. A. van der Veen is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (9 papers), Hormonal and reproductive studies (7 papers) and Ovarian function and disorders (6 papers). E. A. van der Veen collaborates with scholars based in Netherlands, United States and Sri Lanka. E. A. van der Veen's co-authors include Hans de Boer, Marjolein Drent, J.B. Deijen, Wouter R. de Vries, H. P. F. Koppeschaar, Edward H.F. de Haan, Otto Kamp, Jan C. ter Maaten, J. Schoemaker and Louis Gooren and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, American Journal of Public Health and Psychoneuroendocrinology.

In The Last Decade

E. A. van der Veen

40 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. A. van der Veen Netherlands 20 809 384 269 209 199 41 1.4k
Ruth Best United Kingdom 7 998 1.2× 234 0.6× 196 0.7× 216 1.0× 112 0.6× 9 1.3k
Deborah Goodman‐Gruen United States 21 962 1.2× 490 1.3× 130 0.5× 302 1.4× 358 1.8× 23 2.1k
Rona Limor Israel 25 635 0.8× 376 1.0× 107 0.4× 446 2.1× 207 1.0× 62 2.1k
Hiroshi Shinyama Japan 12 1.3k 1.6× 814 2.1× 337 1.3× 402 1.9× 124 0.6× 38 2.3k
Pauline Jamieson United Kingdom 19 1.5k 1.8× 864 2.3× 372 1.4× 349 1.7× 180 0.9× 29 2.5k
A. Franssila-Kallunki Finland 21 720 0.9× 657 1.7× 151 0.6× 556 2.7× 213 1.1× 30 1.7k
D.W. Erkelens Netherlands 25 1.1k 1.3× 497 1.3× 176 0.7× 382 1.8× 217 1.1× 59 2.2k
Panayiotis D. Tsitouras United States 21 946 1.2× 210 0.5× 224 0.8× 346 1.7× 70 0.4× 40 1.7k
George Dimitriadis Greece 16 780 1.0× 396 1.0× 63 0.2× 398 1.9× 154 0.8× 22 1.6k
Reino Ylikahri Finland 26 582 0.7× 263 0.7× 99 0.4× 374 1.8× 43 0.2× 62 1.9k

Countries citing papers authored by E. A. van der Veen

Since Specialization
Citations

This map shows the geographic impact of E. A. van der Veen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. A. van der Veen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. A. van der Veen more than expected).

Fields of papers citing papers by E. A. van der Veen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. A. van der Veen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. A. van der Veen. The network helps show where E. A. van der Veen may publish in the future.

Co-authorship network of co-authors of E. A. van der Veen

This figure shows the co-authorship network connecting the top 25 collaborators of E. A. van der Veen. A scholar is included among the top collaborators of E. A. van der Veen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. A. van der Veen. E. A. van der Veen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Dam, P. Sytze van, A. Aleman, Wouter R. de Vries, et al.. (2000). Growth hormone, insulin-like growthfactor I and cognitive function in adults. Growth Hormone & IGF Research. 10. S69–S73. 100 indexed citations
4.
Alemán, André, H. J. J. Verhaar, Edward H.F. de Haan, et al.. (1999). Insulin-Like Growth Factor-I and Cognitive Function in Healthy Older Men. The Journal of Clinical Endocrinology & Metabolism. 84(2). 471–475. 171 indexed citations
5.
Veen, E. A. van der, et al.. (1999). Growth Hormone (GH) Substitution in Hypogonadotropic, GH-Deficient Women Decreases the Follicle-Stimulating Hormone Threshold for Monofollicular Growth. The Journal of Clinical Endocrinology & Metabolism. 84(2). 590–595. 21 indexed citations
6.
Schoemaker, J., et al.. (1997). Impaired reproductive function in women treated for growth hormone deficiency during childhood. Clinical Endocrinology. 46(6). 681–689. 56 indexed citations
7.
Drent, Marjolein, Ingrid Larsson, T William-Olsson, et al.. (1995). Orlistat (Ro 18-0647), a lipase inhibitor, in the treatment of human obesity: a multiple dose study.. PubMed. 19(4). 221–6. 173 indexed citations
8.
Polderman, Kees H., Louis Gooren, & E. A. van der Veen. (1995). Effects of gonadal androgens and oestrogens on adrenal androgen levels. Clinical Endocrinology. 43(4). 415–421. 24 indexed citations
9.
Ruwaard, Dirk, Rudolf T. Hoogenveen, Harry Verkleij, et al.. (1993). Forecasting the number of diabetic patients in The Netherlands in 2005.. American Journal of Public Health. 83(7). 989–995. 31 indexed citations
10.
Drent, Marjolein & E. A. van der Veen. (1993). Lipase inhibition: a novel concept in the treatment of obesity.. PubMed. 17(4). 241–4. 123 indexed citations
11.
Geldof, A.A., et al.. (1992). Histopathological changes in rat pancreas after fasting and cassava feeding.. Data Archiving and Networked Services (DANS). 6(5). 545–51. 8 indexed citations
12.
Macleod, A F, A J Boulton, D. R. Owens, et al.. (1992). A multicentre trial of the aldose-reductase inhibitor tolrestat, in patients with symptomatic diabetic peripheral neuropathy. North European Tolrestat Study Group.. PubMed. 18(1). 14–20. 20 indexed citations
13.
Haeften, Timon W. van, Thiemo Veneman, John E. Gerich, & E. A. van der Veen. (1991). Influence of gliclazide on glucose-stimulated insulin release in man. Metabolism. 40(7). 751–755. 30 indexed citations
14.
Veen, E. A. van der, et al.. (1991). Growth Hormone Release After the Sequential Use of Growth Hormone Releasing Factor and Exercise. Hormone and Metabolic Research. 23(8). 397–398. 10 indexed citations
15.
Haeften, Timon W. van, et al.. (1991). Decreased insulin secretory capacity and normal pancreatic B‐cell glucose sensitivity in non‐obese patients with NIDDM. European Journal of Clinical Investigation. 21(2). 168–174. 21 indexed citations
16.
Faes, Theo J. C., et al.. (1990). Quantitation of skin vasomotor control in normal subjects and in diabetic patients with autonomic neuropathy. Journal of Neurology. 237(8). 457–460. 5 indexed citations
17.
Lanting, P., J.J. Heimans, J. P. H. Reulen, J. Nauta, & E. A. van der Veen. (1988). Pupillary light reflex and quantitative sensory and motor neural function tests in diabetic patients. Journal of Neurology. 235(4). 245–247. 23 indexed citations
18.
20.
Schouten, J. A., et al.. (1985). Dietary supplementation of omega 3 fatty acids improves insulin sensitivity in non insulin dependent diabetes. 1. 451. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026